NIH funded large trials to see if COVID patients could benefit from ivermectin. They didn't, early data shows.

The randomized, double-blind, placebo-controlled trial – the gold standard for determining effectiveness of drugs – is the largest of its kind.

     

from USATODAY - News Top Stories https://ift.tt/q4CBSTL